Likarda is an animal health company focused on developing next generation cell therapies for pets. Our first product is an insulin-producing cell treatment for pets that suffer from diabetes. We have an underlying platform technology that can produce highly controllable, injectable treatments using hydrogels (materials) better suited for transplant than ever before. Likarda will be testing this product in dogs using the funds raised.